Back to Impax Asset Management Group plc Impax Asset Management Group plc

LGND

30 quarters

Position history for Impax Asset Management Group plcImpax Asset Management Group plc's holdings in Ligand Pharmaceuticals Incorporated

Yes. Impax Asset Management Group holds 130,000 shares of LGND (Ligand Pharmaceuticals), worth $41.1M, as of its Q2 2026 13F filing. It reduced the position by 22,444 shares (-14.7%) from Q1 2026. Impax Asset Management Group has held LGND in every 13F on record since Q1 2019, 30 quarterly filings. LGND is 0.3% of Impax Asset Management Group's reported 13F portfolio.

Current Value

$41.1M

Current Shares

130,000

Total Value Change

+$30.9M

Total Shares Change

+49,041

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
130,000
-14.7%
$41.1M0.3%$316.09
0
2026-Q1
Decreased
152,444
-7.7%
$30.4M0.2%$199.65
0
2025-Q4
Decreased
165,208
-17.5%
$31.2M0.2%$189.07
0
2025-Q3
Decreased
200,208
-23.1%
$35.5M0.2%$177.14
0
2025-Q2
Decreased
260,208
-7.1%
$29.6M0.2%$113.68
0
2025-Q1
Unchanged
280,208
0.0%
$29.5M0.2%$105.14
0
2024-Q4
Unchanged
280,208
0.0%
$30M0.1%$107.15
0
2024-Q3
Unchanged
280,208
0.0%
$28M0.1%$100.09
0
2024-Q2
Increased
280,208
+9.8%
$23.6M0.1%$84.26
31
2024-Q1
Increased
255,208
+24.4%
$18.7M0.1%$73.10
35
2023-Q4
Increased
205,208
+11.3%
$14.7M0.1%$71.42
31
2023-Q3
Increased
184,320
+15.7%
$11M0.0%$59.92
32
2023-Q2
Decreased
159,320
-18.0%
$11.5M0.0%$72.10
0
2023-Q1
Decreased
194,320
-17.1%
$14.3M0.1%$73.56
0
2022-Q4
Unchanged
234,320
0.0%
$15.7M0.1%$66.80
0
2022-Q3
Increased
234,320
+27.1%
$20.2M0.1%$53.72
42
2022-Q2
Increased
184,320
+12.2%
$16.4M0.1%$55.66
32
2022-Q1
Increased
164,320
+21.9%
$18.5M0.1%$70.17
34
2021-Q4
Increased
134,820
+35.7%
$20.8M0.1%$96.36
37
2021-Q3
Increased
99,320
+25.2%
$13.8M0.1%$86.91
34
2021-Q2
Decreased
79,320
-6.0%
$10.4M0.0%$81.84
0
2021-Q1
Decreased
84,411
-32.8%
$12.9M0.1%$95.10
0
2020-Q4
Unchanged
125,567
0.0%
$12.5M0.1%$62.04
0
2020-Q3
Increased
125,567
+7.5%
$12M0.1%$59.46
36
2020-Q2
Unchanged
116,829
0.0%
$13.1M0.1%$69.78
0
2020-Q1
Increased
116,829
+52.1%
$8.5M0.1%$45.36
46
2019-Q4
Increased
76,829
+6.3%
$8M0.1%$65.06
29
2019-Q3
Unchanged
72,303
0.0%
$7.2M0.1%$62.10
0
2019-Q2
Decreased
72,303
-10.7%
$8.3M0.1%$71.21
0
2019-Q1
First report
80,959
-
$10.2M0.1%$78.42
0

Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used